Discussion of the NETTER-2 Trial

https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/08/77/ed/0877eda4-cbb1-bace-3644-e73fb7aced4f/mza_1512576652754283542.jpeg/600x600bb.jpg

NETCast

Podcasting4Associations

37 episodes

2 months ago

NETCast, brought to you by the North American Neuroendocrine Tumor Society (NANETS).

Our episodes host leading neuroendocrine experts who will discuss the latest research, debate pros and cons of various treatment protocols, share information about establishing neuroendocrine centers, and much more.

Visit us at

All content for NETCast is the property of Podcasting4Associations and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

NETCast, brought to you by the North American Neuroendocrine Tumor Society (NANETS).

Visit us at

Discussion of the NETTER-2 Trial

NETCast

26 minutes

1 year ago

Discussion of the NETTER-2 Trial

Join us for Episode 23 of NETCast. Ohio State University Medical Oncology Specialist Dr. Vineeth Sukrithan interviews Dr. Simron Singh professor of medicine at the University of Toronto and co-founder of the Susan Leslie Clinic for Neuroendocrine Tumors. He is also a medical oncologist and affiliate scientist in the Odette Cancer Research Program at Sunnybrook Research Institute. Join us as we review the NETTER-1 study and then discuss the NETTER-2 study. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.